Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat Content
- Conditions
- Steatosis
- Registration Number
- NCT02621853
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Terminated
- Sex
- All
- Target Recruitment
- 3
Inclusion Criteria:<br><br>Adult (=18 years of age), female/male patients who will undergo an open partial liver<br>resection surgery in our institution will be included<br><br>Exclusion Criteria:<br><br>Patients who are scheduled for a metastasectomy or wedge resection where the margin of<br>normal liver that is expected to be removed is less than 1 cm will be excluded.<br><br>In addition, patients who have the following will be excluded:<br><br> - Visual and/or mental impairment<br><br> - Coagulation disorder<br><br> - Cardiac pacemaker and/or defibrillator<br><br> - Deep brain stimulator<br><br> - Bullets or gunshot pellets<br><br> - Cerebral aneurysm clips<br><br> - Cochlear implant<br><br> - Magnetic dental implants<br><br> - Drug infusion devices
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Grade of steatosis determined according to the international standards by histopathological assessment of the liver biopsy specimen
- Secondary Outcome Measures
Name Time Method